- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '95249'
    - '95250'
    - '95251'
    modifier:
    - TC
    - '26'
  conditions:
    any_of:
    - dx_in_value_set: vs_diabetes_type_1_2025_09
    - dx_in_value_set: vs_diabetes_type_2_insulin_dependent_2025_09
    all_of:
    - has_flag: frequent_hypoglycemia_episodes
    - has_flag: hba1c_above_target
    none_of:
    - has_flag: cgm_within_6_months
  logic:
    outcome: PA_REQUIRED
    note: CGM coverage for Type 1 diabetes with frequent hypoglycemia episodes requiring
      enhanced glucose monitoring and glycemic variability assessment
  precedence: 90
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_diabetes_technology_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_48e59e3f6238
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - A4230
    - A4231
    - A4232
    hcpcs:
    - E0784
    - E0785
  conditions:
    any_of:
    - dx_in_value_set: vs_diabetes_type_1_2025_09
    - dx_in_value_set: vs_diabetes_brittle_2025_09
    all_of:
    - has_flag: multiple_daily_injections_inadequate
    - has_flag: diabetes_education_completed
    - min_age: 8
    none_of:
    - has_flag: severe_psychiatric_disorder
    - has_flag: inability_to_operate_device
  logic:
    outcome: PA_REQUIRED
    note: Insulin pump therapy for brittle diabetes management with glycemic variability
      and continuous subcutaneous insulin infusion
  precedence: 95
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_diabetes_technology_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_c9ab6a2ffae5
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    ndc:
    - 0088-2220-33
    - 0088-2225-05
    j_code:
    - J3490
  conditions:
    any_of:
    - dx_in_value_set: vs_diabetes_type_2_2025_09
    - dx_in_value_set: vs_obesity_diabetes_2025_09
    all_of:
    - has_flag: metformin_trial_adequate
    - has_flag: hba1c_above_7_percent
    none_of:
    - dx_in_value_set: vs_diabetic_ketoacidosis_2025_09
    - has_flag: pancreatitis_history
    - has_flag: medullary_thyroid_cancer_history
  logic:
    outcome: PA_REQUIRED
    note: GLP-1 agonist therapy for Type 2 diabetes with obesity and cardiovascular
      benefits including weight reduction
  precedence: 85
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_diabetes_formulary_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_e436c045448d
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '83036'
    - '83037'
    loinc:
    - 4548-4
  conditions:
    any_of:
    - dx_in_value_set: vs_diabetes_type_1_2025_09
    - dx_in_value_set: vs_diabetes_type_2_2025_09
    - dx_in_value_set: vs_prediabetes_2025_09
  utilization_gte:
    count: 4
    period: 12_months
  logic:
    outcome: EDIT
    note: HbA1c testing frequency limits for diabetes monitoring and glycemic control
      assessment with quarterly testing restrictions
  precedence: 75
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_diabetes_monitoring_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_8c39b65742cd
